Evidence map›Paper›PMID 40980865›Full record

ArticleFuture oncology (London, England)2025

[

Hannelore I Coerts, Tessa M van Ginhoven, W Edward Visser, Albert D Windhorst, Menno R Vriens, Marc J C van Treijen, Bart de Keizer, Frederik A Verburg

Abstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in Future oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hannelore I CoertsAcademic Center for Thyroid Disease, Department of Radiology and Nuclear Medicine, Erasmus Medical Centre Rotterdam, Rotterdam, CA, The Netherlands.
Tessa M van GinhovenAcademic Center for Thyroid Disease, Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, CA, The Netherlands.
W Edward VisserAcademic Center for Thyroid Disease, Department of Internal Medicine, Erasmus MC Cancer Institute, Rotterdam, CA, The Netherlands.
Albert D WindhorstDepartment of Radiology and Nuclear Medicine, Amsterdam Medical Center, Amsterdam, The Netherlands.
Menno R VriensDepartment of Surgical Oncology and Gastrointestinal Surgery, Utrecht Medical Center, Utrecht, The Netherlands.
Marc J C van TreijenDepartment of Internal Medicine, Utrecht Medical Center, Utrecht, The Netherlands.
Bart de KeizerDepartment of Radiology and Nuclear Medicine, Utrecht Medical Center, Utrecht, The Netherlands.
Frederik A VerburgAcademic Center for Thyroid Disease, Department of Radiology and Nuclear Medicine, Erasmus Medical Centre Rotterdam, Rotterdam, CA, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThis study aims to evaluate the diagnostic potential of [

methodsThis prospective, multicenter phase-2 clinical trial includes adult patients with DTC and pathologically confirmed cervical lymph node metastases scheduled for thyroidectomy and lymph node dissection (Group 1) and patients with recurrent or persistent DTC scheduled for radioiodine therapy (Group 2). [

Indexed as

Positron Emission Tomography Computed TomographyThyroid NeoplasmsAdultClinical Trials, Phase II as TopicFemaleFluorine RadioisotopesHumansIodine RadioisotopesLymphatic MetastasisMaleMiddle AgedMulticenter Studies as TopicProspective StudiesRadiopharmaceuticalsThyroidectomyFluorine RadioisotopesIodine RadioisotopesRadiopharmaceuticals[18F]tetrafluoroborateDifferentiated thyroid cancerPET/CTradioactive iodinesodium/Iodide symporter

Identifiers

PMID40980865
PMCPMC12520085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.